R. Zolynas

Antithrombotic therapies in patients with heart failure: hypothesis formulation from a research database

M. Cheng, A. Plotnikov, P. Burton, 2010, Pharmacoepidemiology and drug safety.

Determination of plasma and skin concentrations of orbifloxacin in dogs with clinically normal skin and dogs with pyoderma.

R. Zolynas, K. J. Varma, T. Katz, 2002, Veterinary therapeutics : research in applied veterinary medicine.

Efficacy of four commercially available heartworm preventive products against the JYD-34 laboratory strain of Dirofilaria immitis

B. Blagburn, R. Arther, Cristiano von Simson, 2016, Parasites & Vectors.

Assessment of parasitological findings in heartworm-infected beagles treated with Advantage Multi® for dogs (10% imidacloprid + 2.5% moxidectin) and doxycycline

A. Moorhead, M. Dzimianski, T. Settje, 2017, Parasites & Vectors.

Efficacy of four commercially available heartworm preventive products against the JYD-34 laboratory strain of Dirofilaria immitis

B. Blagburn, R. Arther, Cristiano von Simson, 2016, Parasites & Vectors.

Pharmacokinetics and pharmacodynamics of rivaroxaban and its effect on biomarkers of hypercoagulability in patients with chronic heart failure.

M. Gheorghiade, B. Greenberg, M. Mehra, 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Abstract 5020: Effect of Rivaroxaban on Markers of Coagulation in Patients With Acute Coronary Syndromes: An ATLAS ACS-TIMI 46 Substudy

J. Mega, E. Braunwald, L. Jennings, 2009, Circulation.